303 related articles for article (PubMed ID: 17437443)
1. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Suganuma N; Segade F; Matsuzu K; Bowden DW
BJU Int; 2007 May; 99(5):1143-9. PubMed ID: 17437443
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
Ciampi R; Vivaldi A; Romei C; Del Guerra A; Salvadori P; Cosci B; Pinchera A; Elisei R
Mol Cell Endocrinol; 2008 Sep; 291(1-2):57-62. PubMed ID: 18571834
[TBL] [Abstract][Full Text] [Related]
3. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
[TBL] [Abstract][Full Text] [Related]
4. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of glucose transporter (GLUT) 1, 3 and 4 in bovine follicle and corpus luteum.
Nishimoto H; Matsutani R; Yamamoto S; Takahashi T; Hayashi KG; Miyamoto A; Hamano S; Tetsuka M
J Endocrinol; 2006 Jan; 188(1):111-9. PubMed ID: 16394180
[TBL] [Abstract][Full Text] [Related]
6. Glucose transporter expression in English sparrows (Passer domesticus).
Sweazea KL; Braun EJ
Comp Biochem Physiol B Biochem Mol Biol; 2006 Jul; 144(3):263-70. PubMed ID: 16730206
[TBL] [Abstract][Full Text] [Related]
7. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
8. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
[TBL] [Abstract][Full Text] [Related]
9. Facilitative glucose transporter expression in human cancer tissue.
Smith TA
Br J Biomed Sci; 1999; 56(4):285-92. PubMed ID: 10795374
[TBL] [Abstract][Full Text] [Related]
10. Expression of facilitative glucose transporters in gastric tumors.
Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
[TBL] [Abstract][Full Text] [Related]
11. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
13. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
[TBL] [Abstract][Full Text] [Related]
14. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle.
Stuart CA; Yin D; Howell ME; Dykes RJ; Laffan JJ; Ferrando AA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1067-73. PubMed ID: 16803853
[TBL] [Abstract][Full Text] [Related]
15. Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney.
Heilig C; Zaloga C; Lee M; Zhao X; Riser B; Brosius F; Cortes P
Lab Invest; 1995 Nov; 73(5):674-84. PubMed ID: 7474941
[TBL] [Abstract][Full Text] [Related]
16. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
18. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C
Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of facilitative glucose transporters GLUT1 and GLUT3 in the lens.
Merriman-Smith R; Donaldson P; Kistler J
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3224-30. PubMed ID: 10586946
[TBL] [Abstract][Full Text] [Related]
20. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
